About: http://data.cimple.eu/news-article/c6f3dad55ef714bd15f97a6dcf95c3c8ec7916d5e5d815f6971bcf9c     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • People who catch COVID-19 but don't show symptoms may have significantly lower levels of immunity against the virus than those who become severely ill, new research showed Thursday. The majority of virus patients display relatively minor signs of infection, and a small proportion show no symptoms at all. Very little is known about this group, given that they are far less likely to be tested than those who go on to develop severe symptoms including respiratory problems. Researchers based in China compared two groups of individuals infected with COVID-19 in Chongqing's Wanzhou district: 37 who showed symptoms versus 37 who did not. The researchers analysed blood samples from both groups taken a few weeks after recovering and found that just 62.2 percent of the asymptomatic group had short-term antibodies, compared with 78.4 percent of symptomatic patients. After eight weeks of convalescence, antibody presence had fallen in 81.1 percent of asymptomatic patients, compared with 62.2 percent of symptomatic patients. What's more, asymptomatic patients were found to have lower levels of 18 pro- anti-inflammatory cell-signalling proteins than the symptomatic group, suggesting a weaker immune response to the novel coronavirus. Authors of the study, which was published in Nature Medicine, said their findings called into question the idea that everyone who has had coronavirus are immune to future infection. "These data might indicate the risks of using COVID-19 'immunity passports' and support the prolongation of public health interventions, including social distancing, hygiene, isolation of high-risk groups and widespread testing," they wrote. Danny Altmann, a spokesman for British Society for Immunology as well as professor of Immunology at Imperial College London, said the research raised a vital question for combatting COVID-19. "Much immunology data so far has come from analysing the sickest, hospitalised patients, but most people who have been more mildly affected will want to know whether this is likely to have conferred lasting, protective immunity," he said. Altmann said it was "an important and potentially worrying point" that many patients in the study showed a significant decline in antibody levels in just two months. "Though this is quite a small sample size of patients, it is in line with some concerns that natural immunity to coronaviruses can be quite short-lived," said Altmann, who was not involved in the research. pg/mh/dl
schema:headline
  • Mild virus cases may bestow far lower immunity: study
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software